Exclusive

Publication

Byline

Location

Merck Launches Bio Based Solvent Portfolio For High Performance Liquid Chromatography

Singapore, April 23 -- Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography Merck, a leading science and technology company, announced the launch of the first b... Read More


Hong Kong develops AI pathology system for accurate multi-cancer diagnosis

Singapore, April 23 -- A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology analysis system, named&#... Read More


Australia approves MINJUVI(R) (tafasitamab) for treatment of relapsed or refractory follicular lymphoma

Singapore, April 23 -- Biopharmaceutical company Specialised Therapeutics (ST), based in Singapore, has announced that Minjuvi(R) (tafasitamab), in combination with rituximab and lenalidomide, ha... Read More


Jamjoom Pharma and Caritas Egypt launch strategic partnership to enhance eye healthcare

Singapore, April 23 -- Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in Saudi Arabia and across MEA, has announced the signing of a Memorandum of Understanding (MoU) with Caritas... Read More


Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing

Singapore, April 22 -- Andelyn Biosciences, a US-based cell and gene therapy Contract Development and Manufacturing Organization (CDMO), and ENCell Co., a Korea-based advanced biopharmaceutical CDMO, ... Read More


BIO Asia Taiwan 2026 Positions Asia As A Global Biotech Acceleration Hub Powered By AI

Singapore, April 22 -- The annual event, BIO Asia-Taiwan 2026, jointly organized by Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO), will take ... Read More


Andelyn Biosciences And ENCell Forge Strategic US And APAC Manufacturing Bridge For Gene Therapies

Singapore, April 22 -- Andelyn Biosciences, ("Andelyn") a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and ENCell Co., Ltd. ("ENCell"... Read More


KPJ Hospitals, Novo Nordisk sign MoU to tackle Malaysia's obesity crisis

Singapore, April 22 -- KPJ Healthcare Berhad and Novo Nordisk Malaysia have formalised a strategic collaboration through a Memorandum of Understanding (MoU) to strengthen structured,&#1... Read More


TJ Biopharma enters into agreement with Biogen for Felzartamab assets in Greater China Region

Singapore, April 22 -- Biogen Inc. and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio's exclusive rights to felzartamab in the Greater China... Read More


Japan's GHIT Fund announces investment of $8.5 M in five R&D projects

Singapore, April 22 -- The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.37 billion ($8.5 million) in five R&D projects for the development of... Read More